BACKGROUND AND PURPOSE: A limitation in postoperative monitoring of patients with
glioblastoma is the lack of objective measures to quantify residual and recurrent disease …

Object Robust methodology that allows objective, automated, and observer-independent
measurements of brain tumor volume, especially after resection, is lacking. Thus …

Background The potential of a tumour's volumetric measures obtained from pretreatment
MRI sequences of glioblastoma (GBM) patients as predictors of clinical outcome has been …

OBJECTIVE: To investigate the added value of volume on post-contrast three dimensional
(3D) T1-weighted image (T1WI) over classical cross-sectional area on two dimensional (2D) …

The potential impact of different radiological features of glioblastoma multiforme (GBM) on
overall survival (OS) like tumor volume, peritumoral edema (PTE), necrosis volume, necrosis …

Objectives: Delineation of clinical target volume (CTV) is still controversial in glioblastomas.
In order to assess the differences in volume and shape of the radiotherapy target, the use of …

Background Volumetric magnetic resonance imaging (MRI) is now widely available and
routinely used in the evaluation of high-grade gliomas (HGGs). Ideally, volumetric …

Purpose Unambiguous evaluation of glioblastoma (GB) progression is crucial, both for
clinical trials as well as day by day routine management of GB patients. 3D-volumetry in the …

OBJECTIVE In the treatment of glioblastoma, residual tumor burden is the only prognostic
factor that can be actively influenced by therapy. Therefore, an accurate, reproducible, and …

Purpose In glioblastoma, quantitative volumetric measurements of contrast-enhancing or
fluid-attenuated inversion recovery (FLAIR) hyperintense tumor compartments are needed …